Abstract
Head and Neck Squamous Cell Carcinomas (HNSCC) are a collection of tumors located in the upper aerodigestive tract that account for ∼500, 000 new cases annually. Onset of the disease in the population has been attributed to multiple environmental factors. Pathways leading to the development and progression of head and neck squamous cell carcinomas remain largely unknown. Common genetic alterations have been identified, but many of the important genes of activation (oncogenes) or inactivation (tumor suppressor genes) have not yet been identified or characterized. Epigenetic mechanisms, such as histone modifications and DNA methylation, have also become accepted modes of transcriptional inactivation in human malignancies, but are still in their initial stages of evaluation in HNSCC. The majority of DNA methylation studies in HNSCC have focused on genes previously identified as being inactivated in other cancer types. Efforts using genome-wide methylation scanning techniques, such as Restriction Landmark Genomic Scanning (RLGS), have identified novel methylation targets in HNSCC. Due to the involvement of DNA methylation, clinical trials involving demethylating agents, such as Decitabine, alone or in combination with chromatin modifying agents, remain attractive therapeutic options in cancer currently under investigation. Better understanding of the role of DNA methylation in squamous cell carcinomas of the head and neck, as well as the targets of this epigenetic inactivation, may allow for more efficient and earlier detection screenings. In this review, we will discuss our current understanding of epigenetic alterations in HNSCC and their potential use as targets for therapeutic intervention.
Keywords: dna methylation, neck squamous cell carcinomas, aerodigestive tract, epigenetic mechanisms
Current Genomics
Title: DNA Methylation Leaves Its Mark in Head and Neck Squamous Cell Carcinomas (HNSCC)
Volume: 5 Issue: 6
Author(s): L. T. Smith and C. Plass
Affiliation:
Keywords: dna methylation, neck squamous cell carcinomas, aerodigestive tract, epigenetic mechanisms
Abstract: Head and Neck Squamous Cell Carcinomas (HNSCC) are a collection of tumors located in the upper aerodigestive tract that account for ∼500, 000 new cases annually. Onset of the disease in the population has been attributed to multiple environmental factors. Pathways leading to the development and progression of head and neck squamous cell carcinomas remain largely unknown. Common genetic alterations have been identified, but many of the important genes of activation (oncogenes) or inactivation (tumor suppressor genes) have not yet been identified or characterized. Epigenetic mechanisms, such as histone modifications and DNA methylation, have also become accepted modes of transcriptional inactivation in human malignancies, but are still in their initial stages of evaluation in HNSCC. The majority of DNA methylation studies in HNSCC have focused on genes previously identified as being inactivated in other cancer types. Efforts using genome-wide methylation scanning techniques, such as Restriction Landmark Genomic Scanning (RLGS), have identified novel methylation targets in HNSCC. Due to the involvement of DNA methylation, clinical trials involving demethylating agents, such as Decitabine, alone or in combination with chromatin modifying agents, remain attractive therapeutic options in cancer currently under investigation. Better understanding of the role of DNA methylation in squamous cell carcinomas of the head and neck, as well as the targets of this epigenetic inactivation, may allow for more efficient and earlier detection screenings. In this review, we will discuss our current understanding of epigenetic alterations in HNSCC and their potential use as targets for therapeutic intervention.
Export Options
About this article
Cite this article as:
Smith T. L. and Plass C., DNA Methylation Leaves Its Mark in Head and Neck Squamous Cell Carcinomas (HNSCC), Current Genomics 2004; 5 (6) . https://dx.doi.org/10.2174/1389202043348940
DOI https://dx.doi.org/10.2174/1389202043348940 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Research Progress on the Antitumor Effects of Rhein: Literature Review
Anti-Cancer Agents in Medicinal Chemistry Marine Natural Products and Related Compounds as Anticancer Agents: an Overview of their Clinical Status
Anti-Cancer Agents in Medicinal Chemistry High Expression of Human Leukocyte Antigen-G is Associated with a Poor Prognosis in Patients with PDAC
Current Molecular Medicine Next Generation Sequencing in Non-Small Cell Lung Cancer: New Avenues Toward the Personalized Medicine
Current Drug Targets p42.3: An Abductor of Cell Cycle
Anti-Cancer Agents in Medicinal Chemistry Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8
Anti-Cancer Agents in Medicinal Chemistry Classical to Current Approach for Treatment of Psoriasis: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Hedgehog Target Genes: Mechanisms of Carcinogenesis Induced by Aberrant Hedgehog Signaling Activation
Current Molecular Medicine TGFß, a Potent Regulator of Tumor Microenvironment and Host Immune Response, Implication for Therapy
Current Molecular Medicine Monoclonal Antibodies in the Management of Solid Tumors
Current Topics in Medicinal Chemistry Brain Tumour Stem Cells: Implications for Cancer Therapy and Regenerative Medicine
Current Stem Cell Research & Therapy Tumor Targeting with RGD Peptide Ligands-Design of New Molecular Conjugates for Imaging and Therapy of Cancers
Anti-Cancer Agents in Medicinal Chemistry Radiation Therapy in the Management of Lung Cancer
Current Respiratory Medicine Reviews Efficacy and Safety of Antigen-specific Immunotherapy in the Treatment of Patients with Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis
Current Cancer Drug Targets Biomarkers of Alzheimer's Disease Risk in Peripheral Tissues; Focus on Buccal Cells
Current Alzheimer Research Signaling Pathways Responsible for Cancer Cell Invasion as Targets for Cancer Therapy
Current Cancer Drug Targets Chronopharmacology and Antimicrobial Therapeutics
Current Clinical Pharmacology <sup>90</sup>Y-DOTA-Nimotuzumab: Synthesis of a Promising β− Radiopharmaceutical
Current Radiopharmaceuticals Detection of Squamous Cell Carcinoma Antigen with Micro- and Nanogap Interdigitated Electrodes and Gold Nanoparticles
Micro and Nanosystems Current and Emerging Strategies in Bladder Cancer
Anti-Cancer Agents in Medicinal Chemistry